Ozempic and Wegovy Breakthroughs: Heart Health, New Pills, and Beyond

Ozempic and Wegovy Breakthroughs: Heart Health, New Pills, and Beyond

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest on Ozempic, from medical breakthroughs to lifestyle impacts. Listeners, big news from the British Heart Foundation: over one million people with cardiovascular disease will soon get Wegovy, which contains semaglutide like Ozempic, on the National Health Service to prevent heart attacks and strokes. The National Institute for Health and Care Excellence recommends it for those with a body mass index of twenty-seven or higher who have had a heart attack, stroke, or severe artery issues. Clinical trials show it cuts cardiovascular risks, independent of weight loss, and it's given as a weekly injection with diet and exercise. The Obesity Medicine Association reports that in December twenty twenty-five, the Food and Drug Administration approved an oral Wegovy pill for obesity, starting at one point five milligrams and titrating up. It matches the injectable's side effects like stomach issues but offers a no-needle option, taken on an empty stomach. Tirzepatide, sold as Zepbound, leads in effectiveness per their data, with up to twenty-two point five percent average weight loss in trials, beating semaglutide's fourteen point nine percent. Expect one to two new GLP-one drugs yearly from twenty twenty-six, like Lilly's orforglipron oral pill showing eleven point two percent loss, and Novo Nordisk's amycretin with twenty-four point three percent in phase two. Beyond weight, Advisory Board notes semaglutide's approvals for chronic kidney disease in type two diabetes patients and cardiovascular benefits, reducing major events by twenty percent. Studies link it to lower cognitive decline risks and possible fertility boosts from weight loss improving hormones. Always pair these with healthy eating, exercise, and behavioral changes for best results and to preserve muscle. Thanks for tuning in, listeners. Subscribe for more updates. This has been a Quiet Please production, for more check out quietplease.ai. Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(128)

Ozempic Weightloss Unlocked - 15% Weight Loss, Muscle Tradeoffs, and Life After You Stop

Ozempic Weightloss Unlocked - 15% Weight Loss, Muscle Tradeoffs, and Life After You Stop

Host of Ozempic Weightloss Unlocked breaks down semaglutide's real science: STEP One trial results, muscle loss risks, plateaus, and post-stopping effects. Drawing on NEJM research, NYT reporting, and...

19 Syys 12min

Ozempic Weightloss Unlocked - The Rebound Truth: Why Two-Thirds of Weight Comes Back

Ozempic Weightloss Unlocked - The Rebound Truth: Why Two-Thirds of Weight Comes Back

Host explores Ozempic's real results and hidden risks, covering STEP1 trial data, weight regain after stopping, and Oxford research on rebound weight gain. This episode examines why semaglutide works,...

12 Syys 11min

Ozempic Weightloss Unlocked  - 14.9% vs Reality: Trial Data, 105-Pound Wins, and Rebound Truths

Ozempic Weightloss Unlocked - 14.9% vs Reality: Trial Data, 105-Pound Wins, and Rebound Truths

Ozempic Weightloss Unlocked host examines STEP One trial data, GLP-1 science, and side effects through personal stories. The episode covers tirzepatide comparisons, weight regain statistics, and off-l...

5 Syys 12min

Ozempic Weightloss Unlocked - The Truth About Weight Regain, Side Effects, and Real Results

Ozempic Weightloss Unlocked - The Truth About Weight Regain, Side Effects, and Real Results

Host Julia Cartwright breaks down the real science behind Ozempic and Wegovy for weight loss—covering semaglutide's mechanism, clinical trial data, cost, side effects, and regain rumors. This episode ...

29 Elo 12min

Ozempic Weightloss Unlocked - The 15% Truth: Real Results, Side Effects, and Regain

Ozempic Weightloss Unlocked - The 15% Truth: Real Results, Side Effects, and Regain

Host Julia Cartwright breaks down Ozempic's real science: STEP One trial results, how GLP-1 works, common side effects, and what happens after stopping. This episode covers weight regain data from Oxf...

22 Elo 10min

Ozempic Weightloss Unlocked - Real Stories, Results, and Reality - The Truth About Regain After You Stop

Ozempic Weightloss Unlocked - Real Stories, Results, and Reality - The Truth About Regain After You Stop

Host Julia Cartwright breaks down what Ozempic really does—appetite hormones, brain effects, and metabolic benefits. Explore STEP 1 trial results, side effects, weight regain after stopping, and tirze...

15 Elo 10min

Ozempic Weightloss Unlocked - The Truth About Results, Side Effects, and Keeping Weight Off

Ozempic Weightloss Unlocked - The Truth About Results, Side Effects, and Keeping Weight Off

Host Julia Cartwright breaks down the real science behind semaglutide weight loss—how it works, why side effects happen, and what studies reveal about plateaus and muscle loss. Featuring real stories ...

8 Elo 9min

Ozempic Weightloss Unlocked - Real Results, Side Effects, and the Truth About Regain

Ozempic Weightloss Unlocked - Real Results, Side Effects, and the Truth About Regain

Julia Cartwright hosts Ozempic Weightloss Unlocked, covering semaglutide's early weeks, plateaus, side effects, and what happens after stopping. Real stories, expert research, and practical tips on nu...

25 Heinä 12min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
vallattomat
aikalisa
politiikan-puskaradio
rss-viihde-media
ootsa-kuullut-tasta-2
rss-ootsa-kuullut-tasta
tervo-halme
rss-vaalirankkurit-podcast
rss-voi-venaja
et-sa-noin-voi-sanoo-esittaa
otetaan-yhdet
rikosmyytit
rss-asiastudio
rss-ulkopoditiikkaa
rss-raha-talous-ja-politiikka
rss-kaikki-uusiksi
aihe
rss-seksicast
rss-podme-livebox